• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

评估Acticoat烧伤敷料对移植到无胸腺小鼠的培养皮肤替代物中微生物污染的细胞毒性和抗菌活性。

Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.

作者信息

Supp Andrew P, Neely Alice N, Supp Dorothy M, Warden Glenn D, Boyce Steven T

机构信息

Department of Research, Shriners Hospitals for Children, Cincinnati, Ohio 45229-3095, USA.

出版信息

J Burn Care Rehabil. 2005 May-Jun;26(3):238-46.

PMID:15879745
Abstract

Cultured skin substitutes (CSS) have become a useful adjunctive treatment for closure of burn wounds, but CSS are avascular and remain susceptible to microbial destruction longer than split-thickness skin grafts. Irrigation of CSS grafted to burn wounds with a topical antimicrobial solution (TAS) has been shown to promote engraftment of CSS, but TAS usage has potential limitations. Acticoat Burn Dressing (Acticoat; Westaim Biomedical, Exeter, NH) is a silver-coated barrier dressing reported to exhibit antimicrobial activity and to reduce infection in partial-thickness and full-thickness wounds. This study evaluated the cytotoxicity of Acticoat with CSS and the efficacy of Acticoat for the management of microbial contamination in CSS grafted to full-thickness wounds in athymic mice. The cytotoxicity of Acticoat was assessed in preliminary studies after 1 week of exposure to CSS during in vitro maturation or healing on wounds in athymic mice. Histologies were analyzed and cellular viability in the CSS was determined by MTT conversion on days 0, 1, and 7 of Acticoat exposure. At 1, 2, 3, and 4 weeks after grafting, wounds were traced, and areas of healing CSS were calculated by image analysis. At 4 weeks, wound biopsies were evaluated and scored for engraftment of human cells. In a subsequent study, wounds were inoculated with strain SBI-N of Pseudomonas aeruginosa at 1 x 10(5) cfu/wound before the application of CSS or inoculated onto the surface of Acticoat. At 4 weeks, swab cultures were collected from the surface of CSS and scored for the presence of SBI-N. Statistical significance was accepted at the 95% confidence level (P <.05). The data show that exposure in vitro of CSS to Acticoat was cytotoxic within 1 day, but 1 week of exposure in vivo did not injure CSS or inhibit wound healing. Contaminated wounds treated with Acticoat healed similarly to control treatments, with comparable rates of engraftment, and detection of SBI-N on the surface of only one graft. No SBI-N was detected on CSS after inoculation onto the surface of Acticoat. These results suggest that Acticoat may be suitable as a protective dressing to reduce environmental contamination of CSS, if used in conjunction with additional antimicrobials to control organisms present in the wound.

摘要

培养皮肤替代物(CSS)已成为烧伤创面闭合的一种有用辅助治疗方法,但CSS无血管,且比中厚皮片更易长期受到微生物破坏。用局部抗菌溶液(TAS)冲洗移植到烧伤创面的CSS已被证明可促进CSS的植入,但TAS的使用存在潜在局限性。Acticoat烧伤敷料(Acticoat;Westaim Biomedical,埃克塞特,新罕布什尔州)是一种镀银屏障敷料,据报道具有抗菌活性,并可减少部分厚度和全厚度伤口的感染。本研究评估了Acticoat对CSS的细胞毒性以及Acticoat在无胸腺小鼠全厚度伤口移植CSS中管理微生物污染的疗效。在体外成熟或无胸腺小鼠伤口愈合期间,将Acticoat暴露于CSS 1周后,在初步研究中评估Acticoat的细胞毒性。在Acticoat暴露的第0、1和7天,分析组织学并通过MTT转化测定CSS中的细胞活力。移植后1、2、3和4周,追踪伤口,通过图像分析计算愈合CSS的面积。在4周时,评估伤口活检并对人细胞的植入进行评分。在随后的一项研究中,在应用CSS之前或接种到Acticoat表面之前以1×10(5) cfu/伤口的剂量用铜绿假单胞菌菌株SBI-N接种伤口。在4周时,从CSS表面收集拭子培养物并对SBI-N的存在进行评分。在95%置信水平(P <.05)下接受统计学显著性。数据表明,CSS在体外暴露于Acticoat 1天内具有细胞毒性,但在体内暴露1周不会损伤CSS或抑制伤口愈合。用Acticoat治疗的污染伤口与对照治疗的愈合情况相似,植入率相当,且仅在一个移植物表面检测到SBI-N。接种到Acticoat表面后,CSS上未检测到SBI-N。这些结果表明,如果与额外抗菌剂联合使用以控制伤口中存在的微生物,则Acticoat可能适合作为一种保护性敷料以减少CSS的环境污染。

相似文献

1
Evaluation of cytotoxicity and antimicrobial activity of Acticoat Burn Dressing for management of microbial contamination in cultured skin substitutes grafted to athymic mice.评估Acticoat烧伤敷料对移植到无胸腺小鼠的培养皮肤替代物中微生物污染的细胞毒性和抗菌活性。
J Burn Care Rehabil. 2005 May-Jun;26(3):238-46.
2
Comparison of efficacy of 1% silver sulfadiazine and Acticoat for treatment of partial-thickness burn wounds.1%磺胺嘧啶银与Acticoat治疗浅度烧伤创面的疗效比较。
J Med Assoc Thai. 2006 Jul;89(7):953-8.
3
Effective management of microbial contamination in cultured skin substitutes after grafting to athymic mice.移植到无胸腺小鼠后培养皮肤替代物中微生物污染的有效管理。
Wound Repair Regen. 1997 Apr-Jun;5(2):191-7. doi: 10.1046/j.1524-475X.1997.50212.x.
4
A randomized comparative trial between Acticoat and SD-Ag in the treatment of residual burn wounds, including safety analysis.一项关于Acticoat与磺胺嘧啶银治疗烧伤残余创面的随机对照试验,包括安全性分析。
Burns. 2007 Mar;33(2):161-6. doi: 10.1016/j.burns.2006.06.020. Epub 2006 Dec 18.
5
[Multi-center clinical study of acticoat (nanocrystalline silver dressing) for the management of residual burn wounds].[纳米银晶体敷料(Acticoat)用于残余烧伤创面处理的多中心临床研究]
Zhonghua Shao Shang Za Zhi. 2006 Feb;22(1):15-8.
6
Reduced engraftment and wound closure of cryopreserved cultured skin substitutes grafted to athymic mice.移植到无胸腺小鼠身上的冷冻保存培养皮肤替代物的植入减少和伤口愈合情况。
Cryobiology. 1997 Sep;35(2):132-42. doi: 10.1006/cryo.1997.2030.
7
Use of Acticoat dressings in burns: what is the evidence?在烧伤中使用 Acticoat 敷料:有哪些证据?
Burns. 2010 Sep;36(6):751-8. doi: 10.1016/j.burns.2009.04.008. Epub 2010 Mar 25.
8
Assessment of a silver-coated barrier dressing for potential use with skin grafts on excised burns.评估一种涂银屏障敷料在切除烧伤皮肤移植中的潜在应用。
Burns. 2003 Aug;29(5):445-8. doi: 10.1016/s0305-4179(03)00046-9.
9
Cultured skin substitutes reduce requirements for harvesting of skin autograft for closure of excised, full-thickness burns.培养的皮肤替代物减少了为闭合切除的全层烧伤而采集自体皮肤移植的需求。
J Trauma. 2006 Apr;60(4):821-9. doi: 10.1097/01.ta.0000196802.91829.cc.
10
A matched-pair, randomized study evaluating the efficacy and safety of Acticoat silver-coated dressing for the treatment of burn wounds.一项评估Acticoat银涂层敷料治疗烧伤创面疗效和安全性的配对随机研究。
J Burn Care Rehabil. 1998 Nov-Dec;19(6):531-7. doi: 10.1097/00004630-199811000-00013.

引用本文的文献

1
Early Detection, Diagnosis, Prevention, and Treatment of Infection to Avoid Sepsis and Septic Shock in Severely Burned Patients: A Narrative Review.严重烧伤患者感染的早期检测、诊断、预防及治疗以避免脓毒症和感染性休克:一篇叙述性综述
Eur Burn J. 2025 Feb 6;6(1):6. doi: 10.3390/ebj6010006.
2
Development of Biocompatible Electrospun PHBV-PLLA Polymeric Bilayer Composite Membranes for Skin Tissue Engineering Applications.用于皮肤组织工程应用的生物相容电纺 PHBV-PLLA 聚合物双层复合膜的开发。
Molecules. 2024 Apr 29;29(9):2049. doi: 10.3390/molecules29092049.
3
An Overview of Essential Microelements and Common Metallic Nanoparticles and Their Effects on Male Fertility.
必需微量元素和常见金属纳米粒子概述及其对男性生育力的影响。
Int J Environ Res Public Health. 2022 Sep 4;19(17):11066. doi: 10.3390/ijerph191711066.
4
A bioreactor for studying negative pressure wound therapy on skin grafts.用于研究皮肤移植物负压伤口治疗的生物反应器。
Int Wound J. 2022 Mar;19(3):633-642. doi: 10.1111/iwj.13661. Epub 2021 Jul 7.
5
Development of polyurethane foam dressing containing silver and asiaticoside for healing of dermal wound.含银和积雪草苷的聚氨酯泡沫敷料用于皮肤伤口愈合的研究进展
Asian J Pharm Sci. 2019 Jan;14(1):63-77. doi: 10.1016/j.ajps.2018.09.001. Epub 2018 Oct 15.
6
Acticoat versus biobrane: a retrospective review on the treatment of paediatric mid-dermal torso burns.纳米银抗菌敷料与生物皮肤替代品的比较:小儿躯干中厚层烧伤治疗的回顾性研究
Int J Burns Trauma. 2019 Aug 15;9(4):82-87. eCollection 2019.
7
Doxycycline Reduces Scar Thickness and Improves Collagen Architecture.多西环素可减少瘢痕厚度并改善胶原结构。
Ann Surg. 2020 Jul;272(1):183-193. doi: 10.1097/SLA.0000000000003172.
8
Efficacy of hydrosurgical debridement and nanocrystalline silver dressings for infection prevention in type II and III open injuries.水动力清创术联合纳米银敷料预防 II 型和 III 型开放性创伤感染的疗效。
Int Wound J. 2012 Feb;9(1):7-13. doi: 10.1111/j.1742-481X.2011.00822.x. Epub 2011 Nov 10.
9
Topical antimicrobials for burn wound infections.用于烧伤创面感染的局部抗菌药物。
Recent Pat Antiinfect Drug Discov. 2010 Jun;5(2):124-51. doi: 10.2174/157489110791233522.
10
On the toxicity of therapeutically used nanoparticles: an overview.治疗用纳米颗粒的毒性概述
J Toxicol. 2009;2009:754810. doi: 10.1155/2009/754810. Epub 2009 Jan 25.